Enhancing Brown Fat Function in Aging Populations

A recent study published in Science Advances investigates the decline of brown adipose tissue (BAT) activity during aging, a critical factor contributing to metabolic diseases such as obesity and cardiovascular disorders. Conducted by a team led by Professor Joan Villarroya at the University of Barcelona, the research identifies a key molecular mechanism that could be harnessed to enhance BAT function as populations age. This breakthrough explores the potential of pharmacological interventions aimed at supporting metabolic health.

Understanding Brown Adipose Tissue

Brown adipose tissue is known for its role in thermogenesis, which is the process of heat production in organisms. Unlike white adipose tissue, which stores energy, brown fat actively burns calories to generate heat, thereby protecting against obesity and metabolic diseases. The decline of BAT activity with age is associated with:

• Increased obesity risk: As BAT becomes less active, fewer calories are expended, contributing to weight gain.
• Higher incidence of type 2 diabetes: BAT dysfunction is linked with impaired glucose metabolism.
• Cardiovascular diseases: Reduced BAT activity can exacerbate chronic conditions related to aging.

The Mechanism of Decline

The study reveals that the mechanism through which BAT activity diminishes during aging involves a decrease in chaperone-mediated autophagy (CMA). CMA is a cellular process that selectively degrades specific proteins, including repressor proteins that inhibit thermogenesis. This reduction in CMA leads to:

“The function of chaperone-mediated autophagy is essential for selective elimination of proteins that control brown fat activity.” – Professor Joan Villarroya

As CMA declines, BAT's ability to maintain its thermogenic properties diminishes, resulting in reduced metabolic efficiency.

Research Methods

The study utilized animal models to investigate the effects of CMA on BAT activity. The researchers induced changes in CMA levels and observed the corresponding effects on thermogenic activation in brown adipocytes. Key experiments included:

1. Manipulation of CMA levels using lentiviral vectors to either knock down or enhance Lamp2A, a protein essential for CMA.
2. Monitoring changes in the expression of genes involved in thermogenesis.
3. Analyzing the morphology and metabolic function of brown adipose tissue post-treatment.

Table 1: Effect of CMA Manipulation on BAT Activity

Pharmacological Interventions

With the understanding gained from the study, research is now focused on developing drugs that can enhance CMA, thereby preserving BAT function and promoting metabolic health in aging populations. Some promising avenues include:

• Preclinical Drug Trials: Existing compounds initially developed for neurodegenerative diseases are being evaluated for their efficacy in enhancing CMA.
• Clinical Studies: Initial studies in collaboration with hospitals are underway to assess the therapeutic potential of CMA-stimulating agents in patients with low BAT activity.

Table 2: Potential Drugs Targeting CMA

Conclusion

The decline of brown adipose tissue activity with age poses significant health risks, but understanding the underlying mechanisms presents new opportunities for disease prevention. Future research focusing on pharmacologically activating chaperone-mediated autophagy may hold the key to mitigating age-related metabolic disorders, thereby enhancing the quality of life in aging populations.

For further reading and insights, refer to the original study by Alberto Mestres-Arenas et al. titled "Chaperone-mediated autophagy controls brown adipose tissue thermogenic activity" published in Science Advances (2025). [DOI: 10.1126/sciadv.ady0415]

Access the full article at Medical Xpress.

References

[1] Mestre-Arenas, A., et al. (2025). Chaperone-mediated autophagy controls brown adipose tissue thermogenic activity. Science Advances.